IBM stock price forecast: Sideways consolidation likely as IBM drops 3.12% below key averages

Traders Union
All News
Financial News
IBM drops 3.12% today to $285.12

Highlights

IBM’s Q4 revenue and profit exceeded Wall Street expectations, led by a 61% year-over-year surge in mainframe business revenue and robust software growth.
The company ended 2025 with $14.5 billion in cash, invested $8.3 billion in acquisitions, and returned $6.3 billion to shareholders via dividends.
IBM is trading at $285.12, below MA-20 and MA-50 but above MA-200; resistance sits at $302.01, support at $278.31, with sellers dominant short term.

Software, infrastructure growth and acquisitions offset supply chain strains

IBM reported strong fourth-quarter results, surpassing Wall Street’s revenue and profit expectations, driven by growth in software and infrastructure. The mainframe business achieved its best fourth-quarter revenue in over twenty years, with a 61% year-over-year increase when adjusted for currency fluctuations. The company ended 2025 with $14.5 billion in cash, invested $8.3 billion in acquisitions, and returned $6.3 billion to shareholders via dividends. Management noted continued demand for AI and automation solutions, ongoing integration of the Confluent acquisition, progress in quantum computing, and cost pressures in server supply chains and slower Red Hat growth from U.S. federal deal delays.

Seller dominance persists as oversold signals and volatility diverge

Momentum indicators are mixed: MACD and ADX both show neutral signals, suggesting a lack of decisive trend. The Relative Strength Index and Commodity Channel Index point to selling pressure, while Stochastic RSI indicates an oversold condition, highlighting a possible loss of downside momentum. Bull/Bear Power shows recent seller dominance but is shifting from overbought to oversold territory, hinting at response buying near today's lows. The opening saw a moderate gap down from the previous close, with the price currently near today's low in a wide intraday range, marking high volatility and persistent pressure after the open. Despite intraday oversold readings, sellers remain dominant, but there is a notable divergence between short-term weakness and longer-term momentum signals.

Upside bias expected as technicals favor consolidation over decline

Looking ahead to the next five trading days, IBM is expected to trade between $276.00 and $292.00, matching typical volatility for a blue-chip stock. Based on weekly technicals (RSI, ADX, MACD, MA-50), there is a very high probability (more than 80%) that a price increase is more likely, while a decline is less likely. Baseline scenario: the price consolidates in a sideways range near current levels. Bullish scenario: a breakout above $292.00 could target resistance at $302.00, while a drop below $278.00 would expose further weakness toward the $276.00 level.

Anton Kharitonov, expert at Traders Union, sees IBM trading under persistent short-term pressure despite robust fundamentals and long-term technical support. He believes that mixed momentum signals and high intraday volatility reflect uncertainty, with sellers still dominating after strong earnings. Resistance at $292.00 remains key, and failure to hold above $278.00 would signal further weakness. "Base case is sideways consolidation near current levels — any sustained move below $278.00 increases downside risk."

Previously it was reported that IBM is trading below its short- and medium-term moving averages while remaining above its longer-term average, with mixed technical signals as the RSI remains bullish but overbought oscillators and neutral MACD indicate potential exhaustion and ongoing volatility. Key resistance stands near $304.45 and support at $278.03, with the price likely to consolidate within a defined range as bullish reversal probabilities remain elevated despite pronounced recent selling pressure.

Source of Data: IBM Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.